Tags RNA vaccine
Kaneka Eurogentec receives GMP accreditation for new mRNA manufacturing facility – COVID-19 vaccine production ongoing
A new GMP facility for active pharmaceutical ingredient production The new facility audited and accredited by Belgian Authorities will allow the production and the purification of up to 10 g scale ( up to 1 Million doses of vaccine) of RNA for use in human clinical trials and commercial supply, w...
Covid-19 vaccines
@**************************************************************** HeaderWhite *****************************************************************************@ : 261–279 – DOI : 10.1038/nrd.2017.243. } @********************************************************************************* End OneColumn 0...